3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
6
Breast Neoplasms
5
Lymphoma, Large B-Cell, Diffuse
4
Small Cell Lung Carcinoma
3
Ovarian Neoplasms
3
Lymphoma, Mantle-Cell
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Neuroblastoma
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Myeloid, Acute
2
Immunoblastic Lymphadenopathy
2
Advanced Solid Tumors
2
Advanced Malignancies
2
Sarcoma
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Mesothelioma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
Temozolomide
30
Radiotherapy
21
Etoposide
9
Carboplatin
9
Bevacizumab
9
Cyclophosphamide
8
Vincristine
7
Radiation
7
Filgrastim
7
Cisplatin
7
Magnetic Resonance Spectroscopy
6
Irinotecan
5
Ifosfamide
5
Granulocyte Colony-Stimulating Factor
5
etoposide phosphate
4
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Lomustine
4
Everolimus
4
selpercatinib
3
larotrectinib
3
Thalidomide
3
Paclitaxel
3
Nuclear Medicine Department, Hospital
3
Methotrexate
3
Erlotinib Hydrochloride
3
Chemotherapy, Adjuvant
3
Celecoxib
3
Bortezomib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Central Nervous System Neoplasms
×
MLN 8237
×
Clear all
No trials found.